These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 10547091

  • 1. Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.
    Tripodi F, Stanke-Labesque F, Devillier P, Chavanon O, Sessa C, Bessard G.
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):734-40. PubMed ID: 10547091
    [Abstract] [Full Text] [Related]

  • 2. Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veins.
    Hakim A, Stanke-Labesque F, Hoffmann P, Sessa C, Caron F, Cracowski JL, Bessard G.
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):42-7. PubMed ID: 12827025
    [Abstract] [Full Text] [Related]

  • 3. Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
    Li P, Ferrario CM, Brosnihan KB.
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):198-205. PubMed ID: 9700980
    [Abstract] [Full Text] [Related]

  • 4. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 5. Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.
    Stanke F, Cracowski JL, Chavanon O, Magne JL, Blin D, Bessard G, Devillier P.
    Eur J Pharmacol; 1998 Jan 02; 341(1):65-71. PubMed ID: 9489857
    [Abstract] [Full Text] [Related]

  • 6. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
    He GW, Yang CQ.
    J Cardiovasc Pharmacol; 1995 Jul 02; 26(1):13-9. PubMed ID: 7564353
    [Abstract] [Full Text] [Related]

  • 7. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
    Gardan B, Cracowski JL, Sessa C, Hunt M, Stanke-Labesque F, Devillier P, Bessard G.
    J Cardiovasc Pharmacol; 2000 May 02; 35(5):729-34. PubMed ID: 10813374
    [Abstract] [Full Text] [Related]

  • 8. Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide.
    Maeso R, Rodrigo E, Muñoz-Garcia R, Navarro-Cid J, Ruilope LM, Lahera V, Cachofeiro V.
    J Hypertens; 1997 Dec 02; 15(12 Pt 2):1677-84. PubMed ID: 9488222
    [Abstract] [Full Text] [Related]

  • 9. Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein.
    Cracowski JL, Stanke-Labesque F, Sessa C, Hunt M, Chavanon O, Devillier P, Bessard G.
    Can J Physiol Pharmacol; 1999 Oct 02; 77(10):770-6. PubMed ID: 10588481
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV.
    J Pharmacol Exp Ther; 1985 May 02; 233(2):418-24. PubMed ID: 2987481
    [Abstract] [Full Text] [Related]

  • 11. Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries.
    Li P, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 1997 Jun 02; 281(3):1065-70. PubMed ID: 9190837
    [Abstract] [Full Text] [Related]

  • 12. The comparison of the responsiveness of human isolated internal mammary and gastroepiploic arteries to levcromakalim: an alternative approach to the management of graft spasm.
    Akar F, Uydeş-Dogan BS, Tufan H, Aşlamaci S, Köksoy C, Kanzik I.
    Br J Clin Pharmacol; 1997 Jul 02; 44(1):49-56. PubMed ID: 9241096
    [Abstract] [Full Text] [Related]

  • 13. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q, Feenstra M, Pfaffendorf M, Eijsman L, van Zwieten PA.
    J Cardiovasc Pharmacol; 1997 Apr 02; 29(4):451-6. PubMed ID: 9156353
    [Abstract] [Full Text] [Related]

  • 14. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F, Argiolas L, Ruvolo G, del Basso P.
    Br J Pharmacol; 1998 May 02; 124(1):101-10. PubMed ID: 9630349
    [Abstract] [Full Text] [Related]

  • 15. The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo.
    Fukuhara M, Neves LA, Li P, Diz DI, Ferrario CM, Brosnihan KB.
    J Hypertens; 2001 Mar 02; 19(3 Pt 2):561-6. PubMed ID: 11327630
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S, Toson G, Pietra C, Trist DG, Artibani W, Romano O, Corsi M.
    Br J Pharmacol; 1998 Jul 02; 124(5):865-72. PubMed ID: 9692770
    [Abstract] [Full Text] [Related]

  • 17. Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous vein.
    Stanke-Labesque F, Cracowski JL, Bedouch P, Chavanon O, Magne JL, Bessard G, Devillier P.
    J Cardiovasc Pharmacol; 2000 Apr 02; 35(4):531-7. PubMed ID: 10774781
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Montón M, Jiménez A, Núñez A, López-Blaya A, Farré J, Gómez J, Zalba LR, Sánchez de Miguel L, Casado S, López-Farré A.
    J Cardiovasc Pharmacol; 2000 Jun 02; 35(6):906-13. PubMed ID: 10836725
    [Abstract] [Full Text] [Related]

  • 19. Cultured human vascular smooth muscle cells with functional thromboxane A2 receptors: measurement of U46619-induced 45calcium efflux.
    Dorn GW, Sens D, Chaikhouni A, Mais D, Halushka PV.
    Circ Res; 1987 Jun 02; 60(6):952-6. PubMed ID: 2954721
    [Abstract] [Full Text] [Related]

  • 20. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK, Cocks TM.
    Br J Pharmacol; 1995 Oct 02; 116(4):2183-90. PubMed ID: 8564247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.